title: Interpretation of mushroom as a common therapeutic agent for Alzheimer's disease and cardiovascular diseases.
abstract: Alzheimer's disease (AD) and cardiovascular diseases (CVD) share common etiology and preventive strategies. As the population of old-aged people is increasing worldwide, AD complications tend to afflict global healthcare budget and economy heavily. CVD is the prime cause of global mortality and remains a grave threat to both the developed and the developing nations. Mushroom bio-components may be promising in controlling both diseases. Based mainly on in vitro, ex vivo, cell line and animal studies, this review interprets the polypharmaceutic role of mushrooms treating AD and CVD.
authors.affiliation: a Mushroom Research Centre, Institute of Biological Sciences, Faculty of Science, University of Malaya , Kuala Lumpur , Malaysia and.|b Department of Biochemistry and Molecular Biology , Jahangirnagar University , Savar , Dhaka Bangladesh.
authors.forename: Mohammad Azizur
authors.initials: MA
authors.lastname: Rahman
authors.affiliation: a Mushroom Research Centre, Institute of Biological Sciences, Faculty of Science, University of Malaya , Kuala Lumpur , Malaysia and.
authors.forename: Noorlidah
authors.initials: N
authors.lastname: Abdullah
authors.affiliation: a Mushroom Research Centre, Institute of Biological Sciences, Faculty of Science, University of Malaya , Kuala Lumpur , Malaysia and.
authors.forename: Norhaniza
authors.initials: N
authors.lastname: Aminudin
mesh_terms: D000363:Agaricales; D000544:Alzheimer Disease / Q000628:therapy*; D000818:Animals; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000628:therapy*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*
chemical_list: D002316:Cardiotonic Agents; D018696:Neuroprotective Agents
keywords: Amyloid beta; anti-oxidants; bio-active components; neuro-degeneration; vitamins